Diabetes Management

FDA Approves Skytrofa for Pediatric GHD

Skytrofa: A Paradigm Shift in Pediatric Growth Hormone Therapy August 2021 marked a watershed moment in pediatric endocrinology. You know, sometimes breakthroughs arrive quietly, almost unassumingly, but their ripple effects resonate for years. That’s precisely […]

Diabetes Management

FDA Approves Armour Thyroid for Pediatrics

In a move that’s sending ripples of excitement and relief through the pediatric endocrinology community, the U.S. Food and Drug Administration (FDA) recently approved Armour Thyroid for use in children. This isn’t just another regulatory […]